Bioanalytical Systems Financial Statements
Bioanalytical Systems Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | September |
| Annual Report | Company Web Site |
| Investor Relations | Company Web Site |
Bioanalytical Systems Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 45.2 | 43.0 | 42.4 |
| Gross Profit ($ mil.) | 13.8 | 13.8 | 15.4 |
| Operating Income ($ mil.) | 2.4 | (3.4) | 1.3 |
| Total Net Income ($ mil.) | 0.9 | (2.6) | (0.1) |
| Diluted EPS (Net Income) | 0.19 | (0.53) | (0.02) |
Bioanalytical Systems Quarterly Statements
| Quarter Ending Jun 08 | Quarter Ending Mar 08 | Quarter Ending Dec 07 | |
|---|---|---|---|
| Revenue ($ mil.) | 9.8 | 11.0 | 11.4 |
| Gross Profit ($ mil.) | 5.4 | 3.4 | 3.5 |
| Operating Income ($ mil.) | 3.1 | 0.1 | 0.3 |
| Total Net Income ($ mil.) | (0.3) | (0.1) | (0.0) |
| Diluted EPS (Net Income) | (0.05) | (0.03) | 0.00 |
Bioanalytical Systems Stock Quote & Chart
| 12/03/08 11:52:34 EST •
NASDAQ •
2.87
•
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
Bioanalytical Systems Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 0.55 | 0.99 | 1.14 |
| Price/Earnings Ratio | -- | 16.37 | 12.04 |
| Price/Book Ratio | 1.29 | 2.00 | 1.09 |
| Price/Cash Flow Ratio | 9.83 | 10.68 | 7.05 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Bioanalytical Systems Financial Ratios
Bioanalytical Systems Competitive Intelligence
| Covance | MDS | Pharmaceutical Product Development | |
|---|---|---|---|
| Annual Sales ($ mil.) | 1,631.5 | 1,210.0 | 1,414.5 |
| Employees | 8,700 | 5,500 | -- |
| Market Cap ($ mil.) | 5,301.6 | -- | 4,146.1 |
Competitive Landscape





